Meital Ben-David Naim

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Meital Ben-David Naim is an author at Hebrew University of Jerusalem specializing in nanocarriers for therapeutics, polymer-lipid hybrid nanoparticles, and multifunctional nanoparticles.

Publications per year

2022–2022

Publications

Hepatic targeting of the centrally active cannabinoid 1 receptor (CB1R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetes

Shira Hirsch, Liad Hinden, Meital Ben-David Naim et al. · Journal of Controlled Release · 2022 · 16 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

1–1 of 1